Facioscapulohumeral Muscular Dystrophy News and Research

RSS
SLU research halts toxic protein linked to muscular dystrophy in animal models

SLU research halts toxic protein linked to muscular dystrophy in animal models

Study identifies inhibitor that protects cells from toxic DUX4 effects

Study identifies inhibitor that protects cells from toxic DUX4 effects

New model of FSHD could be useful to study effectiveness of experimental therapeutics

New model of FSHD could be useful to study effectiveness of experimental therapeutics

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

SLU researcher reports success in identifying new drug targets for muscular dystrophy

SLU researcher reports success in identifying new drug targets for muscular dystrophy

University Of Minnesota scientists describe breakthrough in research related to FSHD

University Of Minnesota scientists describe breakthrough in research related to FSHD

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

SHIFT Communications expands healthcare practice

SHIFT Communications expands healthcare practice

Australian researchers discover gene involved in muscular dystrophy

Australian researchers discover gene involved in muscular dystrophy

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

EC grants orphan drug designation to aTyr Pharma's Resolaris for treatment of FSHD

EC grants orphan drug designation to aTyr Pharma's Resolaris for treatment of FSHD

Minnesota researchers develop animal research model for FSHD

Minnesota researchers develop animal research model for FSHD

Researchers develop valid humanized model for facioscapulohumeral muscular dystrophy

Researchers develop valid humanized model for facioscapulohumeral muscular dystrophy

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

GSK, Fred Hutch to develop therapeutics against facioscapulohumeral muscular dystrophy

GSK, Fred Hutch to develop therapeutics against facioscapulohumeral muscular dystrophy

New DNA-reading technology could lead to correct genetic diagnosis for muscle-wasting diseases

New DNA-reading technology could lead to correct genetic diagnosis for muscle-wasting diseases

BioTime to market muscle progenitor cell lines bearing hereditary diseases

BioTime to market muscle progenitor cell lines bearing hereditary diseases

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

New treatment strategy for dominant forms of muscular dystrophy

New treatment strategy for dominant forms of muscular dystrophy

MDA announces $13.7M in grants to 40 new muscular dystrophy research initiatives

MDA announces $13.7M in grants to 40 new muscular dystrophy research initiatives